[go: up one dir, main page]
Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Sep;147(3):564–573.

Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Z Qu 1, J M Liebler 1, M R Powers 1, T Galey 1, P Ahmadi 1, X N Huang 1, J C Ansel 1, J H Butterfield 1, S R Planck 1, J T Rosenbaum 1
PMCID: PMC1870968  PMID: 7545872

Abstract

Mast cells play an essential role during development of inflammation after chemical and immunological insults and have been implicated in tissue fibrosis and angiogenesis. The exact contribution of mast cells to these conditions is largely unknown. In this study, we found that a potent angiogenic and mitogenic polypeptide, basic fibroblast growth factor (bFGF), is localized to the majority of mast cells from normal skin and lung and in tissue samples characterized by fibrosis, hyperplasia, and neovascularization. Using specific antibodies to mast cell tryptase, tissue macrophage, and bFGF, we demonstrate that cytoplasmic bFGF immunoreactivity is localized to 96.8 +/- 9.6% of tryptase-positive cells in human fibrotic lung tissue (n = 10), 82.3 +/- 6.9% of tryptase-positive cells in rheumatoid synovia (n = 6), and 93.1 +/- 4.8% of tryptase-positive cells in skin hemangioma (n = 5). Moreover, these tryptase-positive cells comprise a major portion (86 to 97%) of nonvascular cells exhibiting cytoplasmic bFGF staining in these tissues. In contrast, macrophage-like cells contribute less than 10% of the bFGF-positive cells in the same samples. The specificity of the immunostaining results was supported by the finding that cultured human mast cells (HMC-1) express both bFGF mRNA and protein. Our data indicate that mast cells, a primary source of heparin, also serve as a significant source of a heparin-binding growth factor, bFGF, in these disease processes. These observations suggest that mast cells may contribute to these pathological conditions by releasing this polypeptide.

Full text

PDF
564

Images in this article

568Figure 1
on p.568
569Figure 2
on p.569
570Figure 3
on p.570

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson I. Y., Letourneau H. L., Bowden D. H. Comparison of alveolar and interstitial macrophages in fibroblast stimulation after silica and long or short asbestos. Lab Invest. 1991 Mar;64(3):339–344. [PubMed] [Google Scholar]
  2. Bradding P., Feather I. H., Wilson S., Bardin P. G., Heusser C. H., Holgate S. T., Howarth P. H. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol. 1993 Oct 1;151(7):3853–3865. [PubMed] [Google Scholar]
  3. Broadley K. N., Aquino A. M., Hicks B., Ditesheim J. A., McGee G. S., Demetriou A. A., Woodward S. C., Davidson J. M. Growth factors bFGF and TGB beta accelerate the rate of wound repair in normal and in diabetic rats. Int J Tissue React. 1988;10(6):345–353. [PubMed] [Google Scholar]
  4. Broadley K. N., Aquino A. M., Woodward S. C., Buckley-Sturrock A., Sato Y., Rifkin D. B., Davidson J. M. Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest. 1989 Nov;61(5):571–575. [PubMed] [Google Scholar]
  5. Burgess W. H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 1989;58:575–606. doi: 10.1146/annurev.bi.58.070189.003043. [DOI] [PubMed] [Google Scholar]
  6. Bussolati G., Gugliotta P. Nonspecific staining of mast cells by avidin-biotin-peroxidase complexes (ABC). J Histochem Cytochem. 1983 Dec;31(12):1419–1421. doi: 10.1177/31.12.6195216. [DOI] [PubMed] [Google Scholar]
  7. Butterfield J. H., Weiler D., Dewald G., Gleich G. J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res. 1988;12(4):345–355. doi: 10.1016/0145-2126(88)90050-1. [DOI] [PubMed] [Google Scholar]
  8. Caughey G. H. Roles of mast cell tryptase and chymase in airway function. Am J Physiol. 1989 Aug;257(2 Pt 1):L39–L46. doi: 10.1152/ajplung.1989.257.2.L39. [DOI] [PubMed] [Google Scholar]
  9. Caughey G. H. The structure and airway biology of mast cell proteinases. Am J Respir Cell Mol Biol. 1991 May;4(5):387–394. doi: 10.1165/ajrcmb/4.5.387. [DOI] [PubMed] [Google Scholar]
  10. Charlotte F., Win K. M., Preaux A. M., Mavier P., Dhumeaux D., Zafrani E. S., Rosenbaum J. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol. 1993 Apr;169(4):471–476. doi: 10.1002/path.1711690414. [DOI] [PubMed] [Google Scholar]
  11. Crisp A. J., Chapman C. M., Kirkham S. E., Schiller A. L., Krane S. M. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum. 1984 Aug;27(8):845–851. doi: 10.1002/art.1780270802. [DOI] [PubMed] [Google Scholar]
  12. Finklestein S. P., Apostolides P. J., Caday C. G., Prosser J., Philips M. F., Klagsbrun M. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res. 1988 Sep 20;460(2):253–259. doi: 10.1016/0006-8993(88)90370-8. [DOI] [PubMed] [Google Scholar]
  13. Finotto S., Dolovich J., Denburg J. A., Jordana M., Marshall J. S. Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue. Clin Exp Immunol. 1994 Feb;95(2):343–350. doi: 10.1111/j.1365-2249.1994.tb06535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Galli S. J., Gordon J. R., Wershil B. K. Mast cell cytokines in allergy and inflammation. Agents Actions Suppl. 1993;43:209–220. doi: 10.1007/978-3-0348-7324-6_18. [DOI] [PubMed] [Google Scholar]
  15. Glowacki J., Mulliken J. B. Mast cells in hemangiomas and vascular malformations. Pediatrics. 1982 Jul;70(1):48–51. [PubMed] [Google Scholar]
  16. Gonzalez A. M., Buscaglia M., Fox R., Isacchi A., Sarmientos P., Farris J., Ong M., Martineau D., Lappi D. A., Baird A. Basic fibroblast growth factor in Dupuytren's contracture. Am J Pathol. 1992 Sep;141(3):661–671. [PMC free article] [PubMed] [Google Scholar]
  17. Gospodarowicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 1986 Sep;128(3):475–484. doi: 10.1002/jcp.1041280317. [DOI] [PubMed] [Google Scholar]
  18. Gruber B., Poznansky M., Boss E., Partin J., Gorevic P., Kaplan A. P. Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum. 1986 Aug;29(8):944–955. doi: 10.1002/art.1780290802. [DOI] [PubMed] [Google Scholar]
  19. Hawkins R. A., Claman H. N., Clark R. A., Steigerwald J. C. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med. 1985 Feb;102(2):182–186. doi: 10.7326/0003-4819-102-2-182. [DOI] [PubMed] [Google Scholar]
  20. Henke C., Marineili W., Jessurun J., Fox J., Harms D., Peterson M., Chiang L., Doran P. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol. 1993 Oct;143(4):1189–1199. [PMC free article] [PubMed] [Google Scholar]
  21. Horny H. P., Ruck P., Xiao J. C., Kaiserling E. Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-M1. Hum Pathol. 1993 Apr;24(4):355–358. doi: 10.1016/0046-8177(93)90081-q. [DOI] [PubMed] [Google Scholar]
  22. Hunt L. W., Colby T. V., Weiler D. A., Sur S., Butterfield J. H. Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc. 1992 Oct;67(10):941–948. doi: 10.1016/s0025-6196(12)60924-0. [DOI] [PubMed] [Google Scholar]
  23. Jakobsson A. E. Angiogenesis induced by mast cell secretion in rat peritoneal connective tissue is a process of three phases. Microvasc Res. 1994 Mar;47(2):252–269. doi: 10.1006/mvre.1994.1019. [DOI] [PubMed] [Google Scholar]
  24. Katz H. R., Kaye R. E., Austen K. F. Mast cell biochemical and functional heterogeneity. Transplant Proc. 1991 Dec;23(6):2900–2904. [PubMed] [Google Scholar]
  25. Kawabori S., Denburg J. A., Schwartz L. B., Irani A. A., Wong D., Jordana G., Evans S., Dolovich J. Histochemical and immunohistochemical characteristics of mast cells in nasal polyps. Am J Respir Cell Mol Biol. 1992 Jan;6(1):37–43. doi: 10.1165/ajrcmb/6.1.37. [DOI] [PubMed] [Google Scholar]
  26. Kleeberger S. R., Seiden J. E., Levitt R. C., Zhang L. Y. Mast cells modulate acute ozone-induced inflammation of the murine lung. Am Rev Respir Dis. 1993 Nov;148(5):1284–1291. doi: 10.1164/ajrccm/148.5.1284. [DOI] [PubMed] [Google Scholar]
  27. Lemaire I., Beaudoin H., Dubois C. Cytokine regulation of lung fibroblast proliferation. Pulmonary and systemic changes in asbestos-induced pulmonary fibrosis. Am Rev Respir Dis. 1986 Oct;134(4):653–658. doi: 10.1164/arrd.1986.134.4.653. [DOI] [PubMed] [Google Scholar]
  28. Lemaire I., Beaudoin H., Massé S., Grondin C. Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis. Am J Pathol. 1986 Feb;122(2):205–211. [PMC free article] [PubMed] [Google Scholar]
  29. Malone D. G., Wilder R. L., Saavedra-Delgado A. M., Metcalfe D. D. Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum. 1987 Feb;30(2):130–137. doi: 10.1002/art.1780300202. [DOI] [PubMed] [Google Scholar]
  30. Meininger C. J., Zetter B. R. Mast cells and angiogenesis. Semin Cancer Biol. 1992 Apr;3(2):73–79. [PubMed] [Google Scholar]
  31. Norrby K., Jakobsson A., Simonsen M., Sörbo J. Increased angiogenesis in diabetes. Experientia. 1990 Aug 15;46(8):856–860. doi: 10.1007/BF01935538. [DOI] [PubMed] [Google Scholar]
  32. Norrby K., Jakobsson A., Sörbo J. Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57(4):251–256. doi: 10.1007/BF02899089. [DOI] [PubMed] [Google Scholar]
  33. Norrby K., Jakobsson A., Sörbo J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;52(3):195–206. doi: 10.1007/BF02889963. [DOI] [PubMed] [Google Scholar]
  34. Norrby K., Jakobsson A., Sörbo J. Quantitative angiogenesis in spreads of intact rat mesenteric windows. Microvasc Res. 1990 May;39(3):341–348. doi: 10.1016/0026-2862(90)90047-u. [DOI] [PubMed] [Google Scholar]
  35. Planck S. R., Huang X. N., Robertson J. E., Rosenbaum J. T. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):924–930. [PubMed] [Google Scholar]
  36. Pulford K. A., Rigney E. M., Micklem K. J., Jones M., Stross W. P., Gatter K. C., Mason D. Y. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 1989 Apr;42(4):414–421. doi: 10.1136/jcp.42.4.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Qu Z., Garcia C. H., O'Rourke L. M., Planck S. R., Kohli M., Rosenbaum J. T. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994 Feb;37(2):212–220. doi: 10.1002/art.1780370210. [DOI] [PubMed] [Google Scholar]
  38. Qu Z., Picou M., Dang T. T., Angell E., Planck S. R., Hart C. E., Rosenbaum J. T. Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat. Am J Pathol. 1994 Nov;145(5):1127–1139. [PMC free article] [PubMed] [Google Scholar]
  39. Root L. L., Shipley G. D. Human dermal fibroblasts express multiple bFGF and aFGF proteins. In Vitro Cell Dev Biol. 1991 Oct;27A(10):815–822. doi: 10.1007/BF02631248. [DOI] [PubMed] [Google Scholar]
  40. Rothe M. J., Nowak M., Kerdel F. A. The mast cell in health and disease. J Am Acad Dermatol. 1990 Oct;23(4 Pt 1):615–624. doi: 10.1016/0190-9622(90)70264-i. [DOI] [PubMed] [Google Scholar]
  41. Ruck P., Horny H. P., Kaiserling E. Immunoreactivity of human tissue mast cells: nonspecific binding of primary antibodies against regulatory peptides by ionic linkage. J Histochem Cytochem. 1990 Jun;38(6):859–867. doi: 10.1177/38.6.2335741. [DOI] [PubMed] [Google Scholar]
  42. Saksela O., Moscatelli D., Sommer A., Rifkin D. B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol. 1988 Aug;107(2):743–751. doi: 10.1083/jcb.107.2.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schulman E. S. The role of mast cells in inflammatory responses in the lung. Crit Rev Immunol. 1993;13(1):35–70. [PubMed] [Google Scholar]
  44. Sommer A., Rifkin D. B. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J Cell Physiol. 1989 Jan;138(1):215–220. doi: 10.1002/jcp.1041380129. [DOI] [PubMed] [Google Scholar]
  45. Sunderkötter C., Steinbrink K., Goebeler M., Bhardwaj R., Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994 Mar;55(3):410–422. doi: 10.1002/jlb.55.3.410. [DOI] [PubMed] [Google Scholar]
  46. Suzuki N., Horiuchi T., Ohta K., Yamaguchi M., Ueda T., Takizawa H., Hirai K., Shiga J., Ito K., Miyamoto T. Mast cells are essential for the full development of silica-induced pulmonary inflammation: a study with mast cell-deficient mice. Am J Respir Cell Mol Biol. 1993 Nov;9(5):475–483. doi: 10.1165/ajrcmb/9.5.475. [DOI] [PubMed] [Google Scholar]
  47. Walls A. F., Jones D. B., Williams J. H., Church M. K., Holgate S. T. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol. 1990 Oct;162(2):119–126. doi: 10.1002/path.1711620204. [DOI] [PubMed] [Google Scholar]
  48. Wershil B. K., Murakami T., Galli S. J. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol. 1988 Apr 1;140(7):2356–2360. [PubMed] [Google Scholar]
  49. Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991 Feb 22;64(4):841–848. doi: 10.1016/0092-8674(91)90512-w. [DOI] [PubMed] [Google Scholar]
  50. van den Broek M. F., van den Berg W. B., van de Putte L. B. The role of mast cells in antigen induced arthritis in mice. J Rheumatol. 1988 Apr;15(4):544–551. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES